Methods and compositions for acidizing and stabilizing formation of fracture faces in the same treatment

1. A method comprising:

introducing an acidizing and formation stabilizing treatment fluid into a subterranean formation, the acidizing and formation stabilizing treatment fluid comprising a base fluid, an in situ acid generating agent, and an acid-catalyzed, curable resin;

wherein the acid-catalyzed, curable resin is encapsulated with a degradable capsule;

wherein the in situ acid generating agent generates a first portion of acid in the subterranean formation, the first portion of acid creating or enhancing one or more microfissures therein;

wherein the capsule undergoes a degradation after a predetermined amount of time, generating an unencapsulated acid-catalyzed, curable resin; and

wherein the in situ acid generating agent generates a second portion of acid in the subterranean formation, and the second portion of acid catalyzes a reaction whereby the unencapsulated acid-catalyzed, curable resin is cured.

2. The method of claim 1 , wherein the in situ acid generating agent comprises an ammonium salt of an organic acid or an inorganic acid.

3. The method of claim 2 , wherein the ammonium salt of an organic acid or an inorganic acid is selected from the group consisting of ammonium formate, ammonium oxalate, ammonium bisulfite, ammonium bisulfate, monobasic ammonium phosphate, dibasic ammonium phosphate, ammonium nitrate, ammonium sulfamate, ammonium sulfate, ammonium sulfite, and combinations thereof.

4. The method of claim 1 , wherein the in situ acid generating agent comprises an acid ester selected from methanesulfonic acid or an ester of an organic acid.

5. The method of claim 1 , wherein the acid-catalyzed, curable resin comprises one selected from the group consisting of monopolymers of fufuryl alcohol; furan resin; resins obtained by condensation of phenol with furfuryl alcohol; furfuryl-ketone polymers; phenol formaldehyde resins; resin from the condensation of 2,2′-biphenol, ethylene diamine and formaldehyde; melamine resins; alkyldiamino resins; urea formaldehyde resins; and combinations thereof.

6. The method of claim 1 , wherein the encapsulating agent comprises a capsule material selected from the group consisting of gelatin, gum arabic, starches, shellac, and rosin, polyvinyl alcohol, polyethylene, polypropylene, polystyrene, polyacrylamides, polyethers, polyesters, polyamides, polybutadiene, polyisoprene, silicones, epoxies, polyurethanes, polyurethane copolyethers, alkylacrylate-acrylic acid copolymer, and combinations thereof.

7. The method of claim 1 , wherein the capsule is degraded by thermal degradation, chemically induced degradation, exposure to a shear force, or a combination thereof.

8. The method of claim 1 , wherein degradation of the capsule begins after a microfissure has been formed or enhanced by an acid.

9. The method of claim 1 , wherein the cured resin stabilizes, consolidates, and/or strengthens a portion of the subterranean formation surrounding the one or more microfissures.

10. The method of claim 1 , further comprising mixing the fracturing fluid using mixing equipment.

11. The method of claim 1 , wherein the in situ acid generating agent is selected from the group consisting of a lactic acid derivative, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, ethylene glycol monoformate, ethylene glycol diformate, diethylene glycol diformate, glyceryl monoformate, glyceryl diformate, glyceryl triformate, triethylene glycol diformate, formate esters of pentaerythritol, and any combination thereof.

12. The method of claim 1 , wherein the in situ acid generating agent is selected from the group consisting of paratoluene sulfonate ester, phosphonate ester, trimethyl formate, methyl methanesulfonate, methyl trifluoroacetate, and any combination thereof.

13. The method of claim 1 , wherein the in situ acid generating agent is present in the treatment fluid in an amount between 1% to 25%.

14. The method of claim 1 , wherein the acid-catalyzed, curable resin is present in the treatment fluid in an amount between 1% to 25%.

15. The method of claim 1 , wherein the degradable capsule has a size between 0.1 to 100 microns.

16. The method of claim 1 , wherein the treatment fluid has a pH of 4 to 11.

17. The method of claim 1 , wherein the base fluid is an aqueous base fluid, an aqueous-miscible fluid, a water-in-oil emulsion, an oil-in-water emulsion, or any combination thereof.

18. The method of claim 1 , wherein the treatment fluid further comprises an additive selected from the group consisting of a salt; a weighting agent; a fluid loss control agent; an emulsifier; a dispersion aid; a corrosion inhibitor; an emulsion thinner; an emulsion thickener; a gelling agent; a surfactant; a particulate; a proppant particulate; a cutting agent; a lost circulation material; a gas; a foaming agent; a pH control additive; a breaker; a biocide; a crosslinking agent; a stabilizer; a chelating agent; a scale inhibitor; a gas hydrate inhibitor; a mutual solvent; an oxidizer; a reducer; a friction reducer; a clay stabilizing agent; and

any combination thereof.

19. The method of claim 1 , wherein the treatment fluid is gelled, foamed, or gelled and foamed.

20. The method of claim 1 , further comprising pumping the treatment fluid with a pump.